Sylvie van der Werf Selected Research

Sylvie van der Werf Research Topics

Disease

32	Human Influenza (Influenza) 01/2022 - 05/2001
24	Infections 07/2022 - 07/2001
11	COVID-19 01/2022 - 01/2020
3	Virus Diseases (Viral Diseases) 01/2021 - 07/2001
3	Pneumonia (Pneumonitis) 01/2020 - 01/2007
2	Coronavirus Infections 01/2021 - 12/2020
2	Respiratory Tract Infections (Respiratory Tract Infection) 08/2013 - 01/2009
2	Influenza in Birds (Avian Flu) 02/2009 - 01/2008
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 07/2022
1	RNA Virus Infections 07/2022
1	Lymphopenia (Lymphocytopenia) 10/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2020
1	Viremia 05/2014
1	Bacterial Meningitis 08/2013
1	Pneumococcal Infections 08/2013
1	Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis) 08/2013
1	Respiratory Insufficiency (Respiratory Failure) 06/2013
1	Weight Loss (Weight Reduction) 08/2011
1	Tetanus 05/2010
1	Neoplasms (Cancer) 08/2008
1	Hepatocellular Carcinoma (Hepatoma) 08/2008
1	Severe Acute Respiratory Syndrome 07/2007
1	Communicable Diseases (Infectious Diseases) 02/2004
1	Superinfection 05/2003

Drug/Important Bio-Agent (IBA)

18	VaccinesIBA 01/2022 - 07/2001
8	AntibodiesIBA 01/2022 - 01/2009
6	Antiviral Agents (Antivirals)IBA 07/2022 - 01/2019
6	Influenza Vaccines (Influenza Vaccine)FDA Link 12/2019 - 05/2010
5	Proteins (Proteins, Gene)FDA Link 10/2020 - 07/2007
4	Neuraminidase (Sialidase)IBA 01/2020 - 12/2009
4	Viral RNAIBA 01/2019 - 05/2001
3	CytokinesIBA 01/2022 - 05/2010
3	RNA (Ribonucleic Acid)IBA 12/2020 - 07/2001
3	Oseltamivir (Tamiflu)FDA Link 01/2020 - 11/2010
3	Hemagglutinins (Hemagglutinin)IBA 05/2014 - 12/2009
3	Zanamivir (Relenza)FDA Link 01/2012 - 01/2007
2	Immunoglobulin A (IgA)IBA 01/2022 - 12/2021
2	Neutralizing AntibodiesIBA 01/2021 - 05/2010
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 08/2013
2	Biological ProductsIBA 11/2017 - 02/2004
2	Complement System Proteins (Complement)IBA 01/2012 - 01/2009
2	AntigensIBA 04/2011 - 07/2001
2	NucleoproteinsIBA 02/2009 - 07/2001
2	RibonucleoproteinsIBA 01/2008 - 06/2007
1	Pattern Recognition ReceptorsIBA 07/2022
1	RNA Polymerase IIIIBA 07/2022
1	LigandsIBA 07/2022
1	InterferonsIBA 01/2022
1	SARS-CoV-2 spike proteinIBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	HaptoglobinsIBA 01/2022
1	Immunoglobulin G (IgG)IBA 12/2021
1	COVA1-18IBA 10/2021
1	mRNA VaccinesIBA 09/2021
1	COVID-19 VaccinesIBA 09/2021
1	Messenger RNA (mRNA)IBA 09/2021
1	Nucleic AcidsIBA 01/2021
1	NanovaccinesIBA 01/2021
1	RNA Precursors (Precursor, mRNA)IBA 10/2020
1	Histones (Histone)IBA 10/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2020
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2020
1	UbiquitinIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Viral ProteinsIBA 01/2020
1	Ligases (Synthetase)IBA 01/2020
1	1- (3,4- dihydroxyphenyl)- 2- (3- (4- carbamylphenyl)- 1- methylpropylamino)ethanolIBA 01/2019
1	AntipyreticsIBA 11/2017
1	Indicators and Reagents (Reagents)IBA 11/2017
1	CI 22IBA 10/2017
1	Antigen-Antibody Complex (Immune Complex)IBA 05/2014
1	ElementsIBA 03/2012
1	Interleukin-12 (IL 12)IBA 08/2011
1	Interleukin-2 (IL2)IBA 08/2011
1	Liposomes (Liposome)IBA 08/2011
1	Sialic AcidsIBA 01/2011
1	RNA Polymerase II (RNA Polymerase B)IBA 02/2009
1	Peptides (Polypeptides)IBA 08/2008
1	DNA VaccinesIBA 07/2007
1	RNA Polymerase I (Polymerase I, RNA)IBA 06/2007
1	Interferon-gamma (Interferon, gamma)IBA 05/2003
1	Interleukin-10 (Interleukin 10)IBA 05/2003
1	Virulence Factors (Pathogenicity Factors)IBA 05/2003
1	Capsules (Microcapsules)IBA 05/2003
1	DNA (Deoxyribonucleic Acid)IBA 07/2001

Therapy/Procedure

3	Artificial Respiration (Mechanical Ventilation) 05/2014 - 01/2009
2	Therapeutics 01/2022 - 01/2007
1	Personal Protective Equipment 01/2021
1	Ambulatory Care (Outpatient Care) 01/2021
1	Extracorporeal Membrane Oxygenation 06/2013
1	Immunotherapy 08/2008
1	Aftercare (After-Treatment) 01/2007